Business Activity. For a period of one year following the initial Closing under the Series D Agreement the Company shall not change the nature of its business activity if such change would render the Company ineligible as provided in 13 C.F.R. Section 107.720.
Appears in 2 contracts
Samples: Investors’ Rights Agreement (Riverbed Technology, Inc.), Investors' Rights Agreement (Placeware Inc)
Business Activity. For a period of one year following the initial Closing under the Series D Purchase Agreement the Company shall not change the nature of its business activity if such change would render the Company ineligible as provided in 13 C.F.R. Section 107.720.
Appears in 2 contracts
Samples: Investors’ Rights Agreement (LDR Holding Corp), Investor Rights Agreement (Veraz Networks, Inc.)
Business Activity. For a period of one year following the initial Closing under the Series D Agreement C Purchase Agreement, the Company shall not change the nature of its business activity if such the change would render the Company ineligible as provided in 13 C.F.R. CFR Section 107.720.
Appears in 2 contracts
Samples: Investor Rights Agreement (Digimarc Corp), Investor Rights Agreement (Digimarc Corp)
Business Activity. For a period of one year following the initial Closing under the Series D Purchase Agreement the Company shall not change the nature of its business activity if such change would render the Company ineligible as provided in 13 C.F.R. Section 107.720.
Appears in 2 contracts
Samples: Investor Rights Agreement (Rally Software Development Corp), Investor Rights Agreement (Veraz Networks, Inc.)
Business Activity. For a period of one year following the initial Closing under the Series D Agreement Closing, the Company shall not change the nature of its business activity if such change would render the Company ineligible as provided in 13 C.F.R. Section 107.720.
Appears in 2 contracts
Samples: Investors' Rights Agreement (Coulter Pharmaceuticals Inc), Securities Purchase Agreement (Spatial Technology Inc)
Business Activity. For a period of one year following the initial Second Closing under the Series D Purchase Agreement the Company shall not change the nature of its business activity if such change would render the Company ineligible as provided in 13 C.F.R. Section 107.720.
Appears in 2 contracts
Samples: Investor Rights Agreement (Revance Therapeutics, Inc.), Investor Rights Agreement (Revance Therapeutics, Inc.)
Business Activity. For a period of one year following the initial Closing under closing date of the Series D Agreement investment, the Company shall not change the nature of its business activity if such change would render the Company ineligible as provided in 13 C.F.R. Section 107.720.
Appears in 1 contract
Business Activity. For a period of one year following the initial Closing under the Series D Purchase Agreement the Company shall not change the nature of its business activity if such change would render the Company ineligible as provided in 13 C.F.R. C.P.R. Section 107.720.
Appears in 1 contract
Business Activity. For a period of one (1) year following the initial Closing under the Series D B Purchase Agreement the Company shall not change the nature of its business activity if such change would render the Company ineligible as provided in 13 C.F.R. Section 107.720.
Appears in 1 contract
Samples: Investor Rights Agreement (SGX Pharmaceuticals, Inc.)
Business Activity. For a period of one year following the initial Closing under the Series D C Agreement the Company shall not change the nature of its business activity if such change would render the Company ineligible as provided in 13 C.F.R. Section 107.720.
Appears in 1 contract
